Actively Recruiting
Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers
Led by WellSpan Health · Updated on 2025-03-28
350
Participants Needed
1
Research Sites
349 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to answer whether use of a Vcare® intrauterine manipulator leads to an increased incidence of positive peritoneal cytology in patients undergoing surgical management of early stage (FIGO stage I/II) endometrial cancer.
CONDITIONS
Official Title
Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subjects age 18 or older able to give informed consent
- Biopsy diagnosed endometrial cancer including endometrioid, serous, mucinous, and clear cell histologies
- Planned standard of care surgical management of early stage endometrial cancer
- No clinical evidence of disseminated intraperitoneal disease
You will not qualify if you...
- Final pathology does not confirm endometrial cancer including endometrioid, serous, mucinous, and clear cell histology
- Evidence of disseminated intraperitoneal disease
- Subject is not a surgical candidate
- Subject chooses fertility sparing or non-operative management
- Subject is unable to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Wellspan Health
York, Pennsylvania, United States, 17403
Actively Recruiting
Research Team
G
Graham Brown, DO
CONTACT
E
Eav Lim, DO
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here